Avalon GloboCare, a New Jersey-based clinical-stage global developer of cell-based technologies and therapeutics, has partnered with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to...

Sanofi & Translate Bio expand collaboration to develop mRNA vaccines

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are expanding their existing 2018...

Sarepta & Codiak to research, develop exosome-based therapeutics

Precision medicine specialist, Sarepta Therapeutics, and Codiak BioSciences, a company at the forefront of advancing engineered exosomes as a new class of biologic medicines,...

View the Online Magazine

- Advertisement -

Launches

UK launches antibiotic buying scheme to tackle AMR

The NHS is launching a “pioneering scheme” to provide new antibiotics to patients by offering to pay pharma companies upfront for their work. The move...

First generic remdesivir for COVID-19 treatment launched

Beximco Pharmaceuticals, the Bangladesh-based manufacturer of generic pharma products and APIs, has launched the world’s first generic remdesivir for treating COVID-19. Remdesivir is an antiviral...

Dyno launches to transform gene therapy using AI

Dyno Therapeutics, a Cambridge, Massachusetts-based biotech applying AI to gene therapy has officially launched from stealth mode with its proprietary platform, CapsidMap. The platform enables...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

AstraZeneca to supply Europe with up to 400m doses of Oxford Uni’s COVID-19 vaccine

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400...

COVID-19 could hinder blockchain implementation in pharma supply chains

Even though blockchain stands out as a potential solution to improve pharma supply chains, COVID-19 may become a hindrance rather than a trigger in...

Demand for security of pharma & medical supplies post-COVID drives open standards

Demand from governments and health organisations for greater assurances on the integrity and reliability of pharmaceutical and medical products to treat COVID-19 has prompted...

Gilead’s suspension of China COVID-19 trials should serve as bellwether for studies in other countries – GlobalData

China trials of Gilead Sciences’ antiviral drug remdesivir in patients with mild symptoms of COVID-19 have been suspended due to lack of eligible patients. In...

Approvals

UK approves world first coronavirus treatment

The UK government has immediately authorised the NHS to use the world’s first coronavirus treatment proven to reduce the risk of death. Dexamethasone, an anti-inflammatory...

US approves ViiV’s dispersible dolutegravir for children with HIV

ViiV Healthcare has gained US approval for the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV. Dolutegravir...

Lynparza recommended for approval in EU for pancreatic cancer

Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line maintenance treatment of patients with germline BRCA-mutated (gBRCAm)...

Brilinta approved in US to reduce the risk of first heart attack or stroke

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with...

Tecentriq gains first-line approval in NSCLC

The FDA has approved Roche’s Tecentriq (atezolizumab) as a first-line monotherapy for the treatment of metastatic non-small cell lung cancer (NSCLC), marking its fourth...

European approval for gene therapy to treat SMA

European regulators have granted conditional approval to Novartis company AveXis for the gene therapy Zolgensma (onasemnogene abeparvovec) for the treatment of paediatric patients with...

Manufacturiung

Finance

Gilead acquires equity interest in pioneering immunotherapy company

Gilead Sciences is acquiring a 49.9% equity interest in Pionyr Immunotherapeutics, a privately held San Fran company developing first-in-class cancer immunotherapies. The acquisition – for...

Sanofi positions France at centre of strategy with investment

Sanofi has detailed plans on how it will make significant investments in France to increase its vaccines research and production capacities and contribute in...

Germany invests in mRNA specialist, CureVac

The Federal Republic of Germany will invest €300 million in CureVac, a biopharma developing mRNA-based drugs. The funds will be used by CureVac for the...

Takeda continues divestment programme by offloading portfolio to Celltrion

Takeda has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical products sold exclusively in Asia Pacific...

Research & Development
Latest

Avalon GloboCare & BOKU to advance intranasal & oral COVID-19 vaccine candidate

Avalon GloboCare, a New Jersey-based clinical-stage global developer of cell-based technologies and therapeutics, has partnered with the University of Natural Resources and Life Sciences...

Sanofi & Translate Bio expand collaboration to develop mRNA vaccines

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are expanding their existing 2018...

Sarepta & Codiak to research, develop exosome-based therapeutics

Precision medicine specialist, Sarepta Therapeutics, and Codiak BioSciences, a company at the forefront of advancing engineered exosomes as a new class of biologic medicines,...

New class of precision medicine strips cancer of its DNA defences

A new precision medicine targeting cancer’s ability to repair its DNA has shown promising results in the first clinical trial of the drug class. The...

Tonix & Southern Research expand COVID-19 vaccine collaboration to include T cell study

New York biopharma, Tonix Pharmaceuticals, has expanded its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2...

Appointments

In brief: New head of R&D for Cellbox Solutions

Germany’s Cellbox Solutions has appointed Lonza Pharma and Biotech’s former Head of Biosolutions R&D as its new Head of R&D. Dr Herbert A. Mueller-Hartmann will...

Senior promotions for PTC Therapeutics

New Jersey’s PTC Therapeutics has made a double senior appointment. Matthew Klein has been promoted to Chief Development Officer and Eric Pauwels to Chief Business...

Immune Regulation appoints new CEO

Jonathan Rigby has been appointed CEO of Immune Regulation, a London-based clinical stage biotech focussed on for inflammatory and immunological diseases. Based in the US,...
- Advertisement -

Brilinta approved in US to reduce the risk of first heart attack or stroke

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with...

Tecentriq gains first-line approval in NSCLC

The FDA has approved Roche’s Tecentriq (atezolizumab) as a first-line monotherapy for the treatment of metastatic non-small cell lung cancer (NSCLC), marking its fourth...